Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0344307 (
analgesia
)
28,200
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
GPR7 and GPR8 are orphan G protein-coupled receptors that are highly similar to each other. These receptors are expressed predominantly in brain, suggesting roles in central nervous system function. We have purified an endogenous peptide ligand for GPR7 from bovine hypothalamus extracts. This peptide, termed neuropeptide B (NPB), has a C-6-brominated tryptophan residue at the N terminus. It binds and activates human GPR7 or GPR8 with median effective concentrations (EC(50)) of 0.23 nM and 15.8 nM, respectively. In situ hybridization shows distinct localizations of the prepro-NPB mRNA in mouse brain, i.e., in paraventricular hypothalamic nucleus, hippocampus, and several nuclei in midbrain and brainstem. Intracerebroventricular (i.c.v.) injection of NPB in mice induces hyperphagia during the first 2 h, followed by hypophagia. Intracerebroventricular injection of NPB produces
analgesia
to s.c. formalin injection in rats. Through EST database searches, we identified a putative paralogous peptide. This peptide, termed
neuropeptide W
(
NPW
), also has an N-terminal tryptophan residue. Synthetic human
NPW
binds and activates human GPR7 or GPR8 with EC(50) values of 0.56 nM and 0.51 nM, respectively. The expression of
NPW
mRNA in mouse brain is confined to specific nuclei in midbrain and brainstem. These findings suggest diverse physiological functions of NPB and
NPW
in the central nervous system, acting as endogenous ligands on GPR7 andor GPR8.
...
PMID:Characterization of a family of endogenous neuropeptide ligands for the G protein-coupled receptors GPR7 and GPR8. 1271 37
In the rat, the neuropeptide B/
neuropeptide W
(NPB/
NPW
) system is composed of two ligands, neuropeptide B (NPB) and
neuropeptide W
(
NPW
), and one receptor, GPR7. Although preliminary analyses show roles in feeding, hormone secretion, and
analgesia
, the lack of a detailed anatomical map impairs our understanding of the NPB/
NPW
system. We demonstrate in this report the expression patterns of GPR7, NPB, and
NPW
precursor messenger ribonucleic acid (mRNA) in the rat brain by using in situ hybridization and in situ binding experiments. The amygdala expresses the highest levels of GPR7 mRNA and binding signals. Other nuclei with high levels of expression and binding are the suprachiasmatic and the ventral tuberomamillary nuclei. Moderate levels are seen in the dorsal endopiriform, dorsal tenia tecta, bed nucleus, and the red nucleus. Low levels are in the olfactory bulb, parastrial nucleus, hypothalamus, laterodorsal tegmentum, superior colliculus, locus coeruleus, and the nucleus of the solitary tract. Although the NPB precursor is mostly expressed at low levels in the brain, moderate expression is seen in anterior olfactory nucleus, piriform cortex, median preoptic nucleus, basolateral amygdala, hippocampus, medial tuberal nucleus, substantia nigra, dorsal raphe nucleus, Edinger-Westphal nucleus, and the locus coeruleus. To our surprise, the expression of
NPW
precursor was not detected. Our study greatly expands the preliminary in situ data previously reported. With this map of the NPB/
NPW
system in the rat brain, a better understanding of the functional implications of the system in various behavioral paradigms is now possible.
...
PMID:A study of the rat neuropeptide B/neuropeptide W system using in situ techniques. 1673 66